HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.

Abstract
Polycystic ovary syndrome (PCOS), thrombophilia, and hypofibrinolysis are associated with recurrent pregnancy loss (RPL) and spontaneous abortion (SAB). In 28 Caucasian women, 21 women with PCOS (4 with previous thrombosis, 18 with 1 SAB or more, and 20 with 1 coagulation disorder or more), and 7 women with coagulation disorders-thrombi, we speculated that prospective treatment with enoxaparin-metformin or enoxaparin alone would successfully and safely promote healthy live births compared with previous untreated pregnancies. In 21 women with PCOS, metformin (1.5-2.55 g/day) was given before and during pregnancy with concurrent enoxaparin (60 mg/day). Of 21 PCOS women, 19 women had 40 previous untreated pregnancies, 7 had live births (18%), 3 had elective abortions (ABs) (8%), and 30 had SABs (75%). On enoxaparin-metformin, these 19 women had 24 pregnancies, 20 live births (83%), and 4 SABs (17%); the SAB rate was 4.4-fold lower than previous untreated pregnancies (McNemar's s = 20.8, P < 0. 0001). Two women with PCOS without previous pregnancies, but with previous thrombosis, had 2 pregnancies on enoxaparin-metformin and 2 live births. Of the 7 women with coagulation disorders-thrombi, 4 had 15 previous pregnancies without enoxaparin, with 6 live births (40%), 8 SABs (53%), and 1 elective AB (7%). On enoxaparin, these 4 women had 4 pregnancies, with 4 (100%) live births (McNemar's s = 8.0, P = 0.005). The other 3 women with coagulation disorders-thrombi had 4 pregnancies on enoxaparin with 4 live births. No adverse maternal-fetal side effects were reported on enoxaparin alone or enoxaparin-metformin. Enoxaparin-metformin reduces pregnancy loss in women with PCOS-coagulation disorders and in women with coagulation disorders-thrombi.
AuthorsGanga Ramidi, Naseer Khan, Charles J Glueck, Ping Wang, Naila Goldenberg
JournalTranslational research : the journal of laboratory and clinical medicine (Transl Res) Vol. 153 Issue 1 Pg. 33-43 (Jan 2009) ISSN: 1931-5244 [Print] United States
PMID19100956 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Enoxaparin
  • Hypoglycemic Agents
  • Metformin
Topics
  • Abortion, Habitual (etiology, prevention & control)
  • Abortion, Spontaneous (etiology, prevention & control)
  • Adult
  • Anticoagulants (therapeutic use)
  • Blood Coagulation Disorders (drug therapy, etiology)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Embryo Loss (etiology, prevention & control)
  • Enoxaparin (therapeutic use)
  • Female
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Live Birth
  • Metformin (therapeutic use)
  • Polycystic Ovary Syndrome (complications, drug therapy)
  • Pregnancy
  • Pregnancy Complications, Hematologic (drug therapy)
  • Prospective Studies
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: